Rabusertib (IC-83) is an inhibitor of the cell cycle checkpoint kinase 1 (chk1) with potential chemopotentiating activity. Rabusertib has been used in trials studying the treatment of Cancer, Solid Tumors, Advanced Cancer, Pancreatic Neoplasms, and Non-Small Cell Lung Cancer.
Molecular Weight:
436.3
Purity:
99.87%
CAS Number:
[911222-45-2]
Formula:
C18H22BrN5O3
Target:
PDK|||Chk|||Autophagy
T6084
* VAT and and shipping costs not included. Errors and price changes excepted